Educational Videos

Making Sense of the Alphabet Soup: Vasculitis Medications

Case Presentation One: Overview of Treatment Plan 01:37
Pop Quiz: Which of the following is not a side effect of Prednisone 03:01
Glucocorticoids used in the treatment of vasculitis 03:43
Side effects from Prednisone 04:21
Side effects involving skin, GI tract, hypomania 04:55
Prednisone affects the bones 06:40
Prednisone and elevated blood sugars and infection 08:15
Tocilizumab (TCZ) 10:27
GIACTA: Major Trial for TCZ in Giant Cell Arteritis 12:03
TCZ and Takayasu’s arteritis (TAK) 13:52
Precautions with Tocilizumab (TCZ) 14:20
Case Presentation Two 15:47
Goal of using these medications for vasculitis 17:19
Cyclophosphamide in AAV 18:43
Cyclophosphamide Concerns 21:36
Rituximab 23:35
Common reactions to Rituximab 24:50:00
Azathioprine 31:30:00
Methotrexate 37:09:00
Side effects from medications used in vasculitis 39:38:00

Understanding the various medications used to treat vasculitis seems to require a medical degree, but in this video, Anisha Dua, MD, offers a comprehensive, yet understandable guide to these medications.


Here’s an option if you don’t watch the full video.
Below are 1-2 minute video highlights from this presentation.

How are steroids used to treat and control vasculitis?

What are side effects from Prednisone?

What is Tocilizumab?

What do I need to know about cyclophosphamide?

What is Rituximab?

What do I need to know about Methotrexate?

What are side effects from these meds used to treat vasculitis?

Anisha B. Dua, MD, MPH · Assistant Program Director, Department of Medicine-Rheumatology, Northwestern University, Chicago, Illinois
Dr. Dua joined Northwestern University in March 2019 and is the Director of the Fellowship Program and Associate Professor of Medicine in the Department of Rheumatology. She sees patients at the university’s vasculitis clinic on the main campus in Hyde Park as well as in downtown Chicago. She has a special interest in teaching patients, medical students, and residents about achieving optimal management of autoimmune rheumatic conditions.